Drug company hit with $13 million failure-to-warn verdict 
By:
Sylvia Adcock
Published: December 3, 2010
Tags: Aredia, failure to warn, Novartis, osteonecrosis, product liability, Zometa
A federal jury in North Carolina has returned a verdict of nearly $13 million against pharmaceutical giant Novartis, saying the company failed to adequately warn patients and doctors about the risks of taking the bone-strengthening drugs Zometa and Aredia.
Zometa claims can go forward
By:
Pat Murphy
Published: March 13, 2010
Tags: Aredia, drug litigation, product liability, Zometa
A state presumption in favor of manufacturers does not apply to defeat product liability claims brought by plaintiffs who alleged they suffered severe jaw deterioration after taking the defendant’s bone-strengthening drugs, a U.S. District Court in Tennessee has ruled in denying a motion for summary judgment.
NEW FREE WHITE PAPER: E-Discovery
This FREE e-report brought to you by Lawyers USA contains the latest tips for conducting thorough and successful electronic discovery for your trial in 2012. We’ve analyzed the latest court rulings and trends in e-discovery to help you and your clients avoid sanctions and win your case.
Click here to get your free White Paper today!
